11/7/2009
 
Research Cores
 
Respiratory Effects
Cancer
Study Design
and Statistical Methodology
Exposure Assessment
Study Investigator:
Henry Gong
Co-Investigators:
Bill Linn
Costas Sioutas
 
 
 
 
Study Investigator:
Henry Gong
Co-Investigators:
Bill Linn
John Froines
Costas Sioutas
 
 
Respiratory Effects Research Core
Acute Cardiopulmonary Responses
There are two studies in progress involving cardiopulmonary responses. They are found below:
 
Controlled Laboratory Evaluation of Acute Cardiopulmonary Responses to Concentrated Particulates: Healthy Subjects and Asthmatics
In this project we evaluate the potential cardiopulmonary and inflammatory mechanisms in the responses of human volunteers to controlled exposure to PM2.5 in Southern California. An ambient particle concentrator will be installed, tested, and characterized in a mobile exposure laboratory. A safety study will be followed by controlled exposures of adult asthmatics and healthy controls to concentrated PM2.5. Endpoints will be symptoms, lung function, cardiac electrophysiology, and markers of inflammation and hemostasis in induced sputum and blood.
AND
Acute Cardiopulmonary Responses to Concentrated Ambient Particulate Matter in Human Volunteers
The acute toxicologic responses of adult human volunteers to concentrated ambient particles will be assessed in this investigation. Healthy, asthmatic, and COPD volunteers will be exposed to concentrated fine, coarse, and ultrafine particulates in an exposure chamber to evaluate acute cardiopulmonary and other systemic effects of exposure. The particle concentrator, developed by Dr. Sioutas of the Exposure Assessment Research Core, will enable investigators to utilize actual ambient combustion and photochemically derived particles in controlled laboratory circumstances, at concentrations several-fold higher than on any given ambient day. This will provide an exposure scenario whereby acute cardiopulmonary responses to particles can be more easily modified, if they are the appropriate health outcomes of importance in the human particle exposure pathway.